Abstract
Calumet Specialty Products Partners LP will report fiscal second-quarter results on August 07, 2026 Pre-Market.
Market Forecast
Consensus for the current quarter points to revenue of 1.08 billion US dollars, an estimated year-over-year increase of 16.91%, with EBIT of 56.09 million US dollars, and EPS of -0.13, implying a year-over-year improvement of 60.41%. Forecast methodology implies a modest improvement in profitability versus last year, though adjusted margin metrics were not explicitly provided in consensus.
The company’s operations remain anchored by Specialty Products, while supplemental contributions come from Fuel Products and Performance Brands. Specialty Products appears to be the most promising segment near term with estimated revenue of 705.00 million US dollars and positive year-over-year momentum signaled by improving unit economics.
Last Quarter Review
In the prior quarter, Calumet Specialty Products Partners LP posted revenue of 1.03 billion US dollars, a gross profit margin of -8.50%, GAAP net loss attributable to the parent of -317.00 million US dollars, a net margin of -30.79%, and adjusted EPS of -3.64 year over year down 40.54%.
A key highlight was the significant variance versus internal forecasts driven by EBIT of -171.30 million US dollars, reflecting operational and market headwinds that outpaced expectations.
Main business mix featured 705.00 million US dollars from Specialty Products, 235.80 million US dollars from Fuel Products, and 88.90 million US dollars from Performance Brands, with Specialty Products representing the largest revenue share and the core of margin recovery efforts; year-over-year growth details by segment were not disclosed.
Current Quarter Outlook
Main business: Specialty Products
Specialty Products continues to represent the economic core of Calumet Specialty Products Partners LP’s portfolio and the primary lever for earnings normalization. The quarter’s setup features higher expected throughput and mix skew toward higher-value specialty hydrocarbons, which historically carry better pricing and steadier demand than commodity fuels. With estimated consolidated EBIT of 56.09 million US dollars and EPS of -0.13, consensus implies sequential stabilization following a seasonally weak prior quarter. Margin cadence will be sensitive to feedstock spreads and inventory timing; any narrowing of crude differentials or adverse LIFO effects could soften the gross line from last quarter’s depressed base.
Most promising business: Specialty Products within core mix
Among operating segments, Specialty Products is positioned as the most promising growth contributor this quarter, underpinned by price realizations and mix improvements that support revenue around 705.00 million US dollars. Even a modest uplift in unit margins can translate disproportionately to EBIT given the segment’s scale. Watch for signals on contract pricing resets, end-market demand in lubricants and solvents, and contribution from high-margin sub-verticals. Execution on operating reliability and yield optimization is central to translating revenue into EBIT given last quarter’s volatility.
Stock-price drivers this quarter
Share performance is likely to hinge on three factors: the magnitude of the EBIT rebound versus the prior quarter’s shortfall, management commentary on margin drivers and cost control, and any updates to full-year profitability targets relative to the forecast EPS inflection. A print near the 56.09 million US dollars EBIT mark, coupled with confirmation of a revenue run-rate around 1.08 billion US dollars, would reinforce the case for gradual operational normalization. Conversely, any renewed pressure from feedstock costs, downtime, or weaker specialty demand could keep EPS near the guided loss and delay the recovery narrative.
Analyst Opinions
Most institutional commentary in recent weeks has leaned cautious-to-constructive, highlighting prospects for sequential improvement but stopping short of calling a full earnings inflection. The majority view emphasizes stabilization in Specialty Products and the potential for EBIT recovery toward the mid-50 million US dollars range if feedstock spreads cooperate. Analysts point to the prior quarter’s undershoot as a reminder of execution risk, yet see a path to moderate upside if reliability improves and pricing holds in specialty end-markets.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments